These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23250131)

  • 1. Serum urate and the risk of Parkinson's disease: results from a meta-analysis.
    Shen C; Guo Y; Luo W; Lin C; Ding M
    Can J Neurol Sci; 2013 Jan; 40(1):73-9. PubMed ID: 23250131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urate and the risk of Parkinson's disease in men and women.
    Cortese M; Riise T; Engeland A; Ascherio A; Bjørnevik K
    Parkinsonism Relat Disord; 2018 Jul; 52():76-82. PubMed ID: 29615298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between high uric acid and the risk of Parkinson's disease: A meta-analysis.
    Zhang J; Zeng L; Bu L; Liao H; Wang M; Xiong Y; Cao F
    Medicine (Baltimore); 2024 Jul; 103(30):e38947. PubMed ID: 39058857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide variant by serum urate interaction in Parkinson's disease.
    Nazeri A; Roostaei T; Sadaghiani S; Chakravarty MM; Eberly S; Lang AE; Voineskos AN
    Ann Neurol; 2015 Nov; 78(5):731-41. PubMed ID: 26284320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma urate and risk of Parkinson's disease: A mendelian randomization study.
    Kobylecki CJ; Nordestgaard BG; Afzal S
    Ann Neurol; 2018 Aug; 84(2):178-190. PubMed ID: 30014508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of plasma urate and risk of Parkinson disease in men and women.
    Gao X; O'Reilly ÉJ; Schwarzschild MA; Ascherio A
    Neurology; 2016 Feb; 86(6):520-6. PubMed ID: 26764029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression.
    Ikeda K; Nakamura Y; Kiyozuka T; Aoyagi J; Hirayama T; Nagata R; Ito H; Iwamoto K; Murata K; Yoshii Y; Kawabe K; Iwasaki Y
    Neurodegener Dis; 2011; 8(4):252-8. PubMed ID: 21282940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial.
    Schwarzschild MA; Macklin EA; Bakshi R; Battacharyya S; Logan R; Espay AJ; Hung AY; Bwala G; Goetz CG; Russell DS; Goudreau JL; Parashos SA; Saint-Hilaire MH; Rudolph A; Hare JM; Curhan GC; Ascherio A;
    Neurology; 2019 Oct; 93(14):e1328-e1338. PubMed ID: 31484712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response meta-analysis on urate, gout, and the risk for Parkinson's disease.
    Chang H; Wang B; Shi Y; Zhu R
    NPJ Parkinsons Dis; 2022 Nov; 8(1):160. PubMed ID: 36418349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urate as a predictor of the rate of clinical decline in Parkinson disease.
    Ascherio A; LeWitt PA; Xu K; Eberly S; Watts A; Matson WR; Marras C; Kieburtz K; Rudolph A; Bogdanov MB; Schwid SR; Tennis M; Tanner CM; Beal MF; Lang AE; Oakes D; Fahn S; Shoulson I; Schwarzschild MA;
    Arch Neurol; 2009 Dec; 66(12):1460-8. PubMed ID: 19822770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.
    Schwarzschild MA; Schwid SR; Marek K; Watts A; Lang AE; Oakes D; Shoulson I; Ascherio A; ; Hyson C; Gorbold E; Rudolph A; Kieburtz K; Fahn S; Gauger L; Goetz C; Seibyl J; Forrest M; Ondrasik J
    Arch Neurol; 2008 Jun; 65(6):716-23. PubMed ID: 18413464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urate as a marker of development and progression in Parkinson's disease.
    Constantinescu R; Zetterberg H
    Drugs Today (Barc); 2011 May; 47(5):369-80. PubMed ID: 22013567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants related to urate and risk of Parkinson's disease.
    Hughes KC; Gao X; O'Reilly EJ; Kim IY; Wang M; Weisskopf MG; Schwarzschild MA; Ascherio A
    Parkinsonism Relat Disord; 2018 Aug; 53():4-9. PubMed ID: 29789205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum uric acid levels in patients with Parkinson's disease: A meta-analysis.
    Wen M; Zhou B; Chen YH; Ma ZL; Gou Y; Zhang CL; Yu WF; Jiao L
    PLoS One; 2017; 12(3):e0173731. PubMed ID: 28319195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Serum Urate Change as Parkinson's Disease Progresses?
    Hasimoglu YG; Chen X; Bakshi R; Schwarzschild MA; Macklin EA
    J Parkinsons Dis; 2020; 10(4):1571-1576. PubMed ID: 32773396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson's Disease.
    Sleeman I; Lawson RA; Yarnall AJ; Duncan GW; Johnston F; Khoo TK; Burn DJ
    J Parkinsons Dis; 2019; 9(2):351-359. PubMed ID: 30909247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet, urate, and Parkinson's disease risk in men.
    Gao X; Chen H; Choi HK; Curhan G; Schwarzschild MA; Ascherio A
    Am J Epidemiol; 2008 Apr; 167(7):831-8. PubMed ID: 18326873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One year safety and efficacy of inosine to increase the serum urate level for patients with Parkinson's disease in Japan.
    Iwaki H; Ando R; Miyaue N; Tada S; Tsujii T; Yabe H; Nishikawa N; Nagai M; Nomoto M
    J Neurol Sci; 2017 Dec; 383():75-78. PubMed ID: 29246629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma urate and risk of Parkinson's disease.
    Weisskopf MG; O'Reilly E; Chen H; Schwarzschild MA; Ascherio A
    Am J Epidemiol; 2007 Sep; 166(5):561-7. PubMed ID: 17584757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of Parkinson disease associated with urate in a community-based cohort of older adults.
    Jain S; Ton TG; Boudreau RM; Yang M; Thacker EL; Studenski S; Longstreth WT; Strotmeyer ES; Newman AB
    Neuroepidemiology; 2011; 36(4):223-9. PubMed ID: 21677446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.